Cost-effectiveness analysis of pembrolizumab versus chemotherapy in advanced non-small cell lung cancer in China based on real-world studies
基于真实世界研究的中国晚期非小细胞肺癌患者接受帕博利珠单抗治疗与化疗的成本效益分析
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06242-6
Wan, Ning; Yang, Chen; Wang, Bing; Guo, Ya; He, ZiJian; Lv, YaJuan; Lu, LiQing; Yang, Ning; Xiao, WeiBin; Chen, YongBang; Yuan, Jin; Yang, DanDan; Liu, Tao; Fang, WenFeng; Chen, ZhuoJia; Liang, WeiTing